Form 4 for REGN Regeneron Pharmaceuticals
Accepted 2021-12-14 00:00:00 ET · period of report 2021-12-11 · accession 0001708138-21-000104 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-12-14 | 2021-12-11 | REGN | STAHL NEIL | EVP Research, Development | F - Tax | $664.34 | -753 | 53.1K | -1% | -$500.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-11 | F | D | 753 | $664.34 | 53,130 | D | — | — |